Total medical devices industry cross border deals worth $807.8m were announced globally for September 2022, with the $243.32m acquisition of Medi-Globe being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 82.7% over the previous month of $4.67bn and a drop of 73.3% when compared with the last 12-month average of $3.02bn.
In terms of number of cross border deals, the sector saw a drop of 23.44% with 49 deals in September 2022 when compared to the last 12-month average of 64 deals.
In value terms, Europe led the activity with cross border deals worth $400.85m in September 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedical Devices industry cross border deals in September 2022: Top deals
The top five cross border deals accounted for 69.5% of the overall value during September 2022.
The combined value of the top five cross border deals stood at $561.28m, against the overall value of $807.8m recorded for the month.
The top five medical devices industry cross border deals of September 2022 tracked by GlobalData were:
1) DCC Healthcare’s $243.32m acquisition deal with Medi-Globe
2) The $154.02m acquisition of IZI Medical Products by Halma
3) Bluestem Capital Company, Falcon Vision Global, Marshall Wace and MVM Partners’s $67m venture financing deal with Neurolenses
4) The $50m venture financing of Ceribell by Ally Bridge Group
5) 415 Capital Management, Andera Partners, BioMedPartners, Credit Mutuel Innovation, Go Capital , Karista and Wellington Partners Venture Capital’s $46.94m venture financing deal with TRiCares
